Biodexa stock soars 76% on FDA Fast Track status for eRapa
Biodexa (NASDAQ:BDRX) stock soared 76% in morning trading after the company announced it has received FDA Fast Track designation for its drug eRapa for the treatment of familial adenomatous polyposis, ...
Stocktwits on MSN2h
Biodexa Stock Surges On FDA's Fast-Track Tag For Treatment Of Cancer-Causing Condition: Retail Confidence Peaks
Shares of Biodexa Pharmaceuticals skyrocketed nearly 50% on Monday, hitting their highest level since early December. The ...
'I no fit poo-poo from di normal place again after my colostomy surgery sake of cancer'
E mean say her colostomy na permanent one,- "I go dey poopoo from my stomach for di rest of my life," di doctors seal her anus. "Wen dem tell me say I no go dey fit defecate from my anus again, e bin ...